Spatial signal detection in rats is differentially disrupted by Δ-9- tetrahydrocannabinol, scopolamine, and MK-801

Behavioural Brain Research

Volumn 99, Issue 1, 1999, Pages 27-34

  Presburger, Gadi ^a   Robinson, John K ^a  

^a STONY BROOK UNIVERSITY   (United States)

Author keywords

Acetylcholine; Attention; Cannabinoid; Discrimination; Glutamate; Marijuana; Vigila nce

Indexed keywords

CANNABIS; DIZOCILPINE; DRONABINOL; SCOPOLAMINE;

ALERTNESS; ANIMAL EXPERIMENT; ARTICLE; ASSOCIATION; COGNITION; DRUG EFFECT; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SHORT TERM MEMORY; SIGNAL DETECTION; SPATIAL DISCRIMINATION; SPATIAL MEMORY; TASK PERFORMANCE; VISUAL MEMORY;

ANIMALS; ATTENTION; CUES; DEPRESSION, CHEMICAL; DIZOCILPINE MALEATE; EXCITATORY AMINO ACID ANTAGONISTS; HALLUCINOGENS; INJECTIONS, INTRAVENOUS; MALE; MUSCARINIC ANTAGONISTS; PSYCHOMOTOR PERFORMANCE; RATS; RATS, SPRAGUE-DAWLEY; SCOPOLAMINE; SIGNAL DETECTION (PSYCHOLOGY); SPACE PERCEPTION; TETRAHYDROCANNABINOL;

EID: 0033557801     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-4328(98)00065-5     Document Type: Article

References (49)

1. Aigner T. Δ-9-Tetrahydocannabinol impairs visual recognition memory in rhesus monkeys. Psychopharmacology 1988;95:507-11.
2. Al-Amin HA, Schwarzkopf SB. Effects of the PCP analog dizocilpine on sensory gating: potential relevance to clinical subtypes of schizophrenia. Biol Psychiatry 1996;40:744-54.
3. Baudry M, Lynch G. Properties and substrates of mammalian memory systems. In: Meltzer HY, editor. Psychopharmacology: The Third Generation of Progress. New York: Raven Press, 1988:449-62.
4. Belmore SM, Miller LL. Levels of processing and acute effects of marijuana on memory. Pharmacol Biochem Behav 1980;13:199-203.
5. Buffalo EA, Gillam MP, Allen RR, Paule MG. Acute behavioral effects of MK-801 in rhesus monkeys: assessment using an operant test battery. Pharmacol Biochem Behav 1994;48:935-40.
6. Bushnell PJ. Modeling working and reference memory in rats: effects of scopolamine on delayed matching-to-position. Behav Pharmacol 1990;1:419-27.
7. Bushnell PJ, Oshiro WM, Padnos BK. Detection of visual signals by rats: effects of chlordiazepoxide and cholinergic and adrenergic drugs on sustained attention. Psychopharmacology (Berl) 1997;134:230-41.
8. Campbell KA, Foster TC, Hampson RE, Deadwyler SA. Δ-9-tetrahydrocannabinol differentially effects sensory-evoked potentials in the rat dentate gyrus. J Pharmacol Exp Ther 1986;239:936-40.
9. Campbell KA, Foster TC, Hampson RE, Deadwyler SA. Effects of Δ-9-tetrahydrocannabinol on sensory-evoked potentials in the granule cells in the dentate gyrus of behaving rats. J Pharmacol Exp Ther 1986;239:941-5.
10. Castro CA, Hogan JB, Benson KA, Shehata CW, Landauer MR. Pharmacol Behavioral effects of vehicles: DMSO, ethanol, Tween-20, Tween-80, and emulphor-620. Pharmcol Biochem Behav 1995;48:521-6.
11. Coyle JT, Price DL, DeLong MR. Alzheimer's disease: a disorder of cortical cholinergic innervation. Science 1982;19:1184-90.
12. Dai H, Carey RJ. The NMDA antagonist MK-801 can impair attention to exteroceptive stimuli. Behav Brain Res 1994;62:149-56.
13. Darley CF, Tinklenberg J R, Hollister TE, Atkinson RC. Marijuana and retrieval from short-term memory. Psychopharmacologia 1973;29:231-8.
14. Darley CF, Tinklenberg JR, Roth WT, Hollister LE, Atkinson RC. Influence of marijuana on storage and retrieval processes in memory. Mem Cogn 1973;1:196-200.
15. Davies P, Maloney AJF. Selective loss of central cholinergic neurons in Alzheimer's disease. Lancet 1976;2:1403.
16. Dunne MP, Hartley LR. The effects of scopolamine upon verbal memory: evidence for an attentional hypothesis. Acta Psychol (Amst) 1985;58:205-17.
17. Dunne MP, Hartley LR. Scopolamine and the control of attention in humans. Psychopharmacology (Berl) 1986;89:94-7.
18. Dunnett SB. Comparative effects of cholinergic drugs and lesions of the fimbria-fornix on delayed matching in rats. Psychopharmacology 1985;87:357-63.
19. Emrich HM, Weber MM, Wendl A, Zihl J, Von Meyer L, Hanisch W. Reduced binocular depth inversion as an indicator of cannabis-induced censorship impairment. Pharmacol Biochem Behav 1991;40:689-90.
20. Frey PW, Colliver JA. Sensitivity and responsivity measures for discrimination learning. Learn Motiv 1973;4:327-42.
21. Green DM, Swets JA. Signal Detection Theory and Psychophysics. New York: Wiley, 1974.
22. Hagan JJ, Morris RGM. The cholinergic hypothesis of memory: a review of animal experiments. In: Iversen LL, Iversen SD, Snyder SH, editors. Handbook of Psychopharmacology: Psychopharmacology of the aging nervous system, vol. 20. New York: Plenum Press, 1988:217-323.
23. Hampson RE, Foster TC, Deadwyler SA. Effects of A-9 tetrahydrocannabinol on sensory evoked hippocampal activity in the rat: principle component analysis and sequential dependency. J Pharmacol Exp Ther 1989;251:870-7.
24. Heyser CJ, Hampson RE, Deadwyler SA. Effects of delta-9-tetrahydrocannabinol on delayed match to sample performance in rats: alterations of short-term memory associated with changes in task specific firing of hippocampal cells. J Pharmacol Exp Ther 1993;264:294-307.
25. Hollister LE. Health aspects of cannabis. Pharmacol Rev 1986;38:1-20.
26. Javitt DC, Zukin SR. Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry 1991;148:1301-8.
27. Jones DN, Higgins GA. Effect of scopolamine on visual attention in rats. Psychopharmacology (Berl) 1995;120:142-9.
28. Lichtman AH, Dimen KR, Martin BR. Systemic or intrahippocampal cannabinoid administration impairs spatial memory in rats. Psychopharmacology 1995;119:282-90.
29. Martin BR. Cellular effects of cannabinoids. Psychological Rev 1986;38:45-74.
30. Mallet PE, Beninger RJ. The endogenous cannabinoid receptor agonist anandamide impairs memory in rats. Behav Pharmacol 1996;7:276-86.
31. McCarthy D, Davidson M. Toward a behavioral theory of bias in signal detection. Percept Psychophys 1981;29:371-82.
32. McGaughy J, Turchi J, Sarter M. Crossmodal divided attention in rats: effects of chlordiazepoxide and scopolamine. Psychopharmacology (Berl) 1994;115:213-20.
33. Mendihiratta SS, Varma VK, Dang R, Malhotra AK, Das K, Nehra R. Cannabis and cognitive functions. Br J Addict 1988;83:749-53.
34. Miller LL, Branconnier RJ. Cannabis: effects on memory and the cholinergic limbic system. Psychol Bull 1983;93:441-56.
35. Morris RGM, Anderson E, Lynch GS, Baudry M. Selective impairment of learning and blockade of long-term potentiation by an N-methyl-D-aspartate receptor antagonist, AP5. Nature 1986;319:774-6.
36. Muir JL, Dunnett SB, Robbins TW, Everitt BJ. Attentional functions of the forebrain cholinergic systems: effects of intraventricular hemicholinium, physostigmine, basal forebrain lesions and intracortical graphs on a multiple-choice serial reaction time task. Exp Brain Res 1992;89:611-22.
37. Nakamura EM, da Silva EA, Concilio GV, Wilkinson DA, Masur J. Reversible effects of acute and long-term administration of Δ-9- tetrahydrocannabinol (THC) on memory in the rat. Drug and Alcohol Dependence 1991;28:167-75.
38. Nevin JA. Quantitative analysis. J Exp Anal Beh 1984;42:421-34.
39. Pang K, Williams MJ, Egeth H, Olton DS. Nucleus basalis magnocellularis (NBM) and attention: effects of muscimol injections. Behav Neurosci 1993;107:1031-8.
40. Reisine TD, Yamamura HI, Bird ED, Spokes E, Enna SJ. Pre-and post-synaptic neurochemical alterations in Alzheimer's disease. Brain Res 1978;159:477-82.
41. Robinson JK, Crawley JN. Intraventricular galanin impairs delayed non-matching to sample performance in the rat. Behav Neurosci 1993;107:274-83.
42. Robinson JK. Pharmacological models of amnesia: a re-examination of the effects of cholinergic muscarinic antagonist scopolamine and NMDA-receptor antagonist MK-801 on delayed nonmatching-to-position in rats. Psychobiology 1997;25:229-35.
43. Robinson JK, Mao J. Differential effects on delayed nonmatching-to-position in rats of microinjections of muscarinic receptor antagonist scopolamine or NMDA receptor antagonist MK-801 into the dorsal or the ventral extent of the hippocampus. Brain Res 1997;765:51-60.
44. Sakurai Y, Wenk G. The interaction of acetylcholinergic and serotonergic neural systems on performance in the continuous non-matching to sample task. Brain Res 1990;519:118-21.
45. Tan S, Kirk RC, Abraham WC, McNaughton N. Effects of the NMDA antagonists CPP and MK-801 on delayed conditional discrimination. Psychopharmacology 1989;98:556-60.
46. U.S. Department of Health and Human Services. NIH Guide for the Care and Use of Laboratory Animals. Publication No. NIH 85-23. Washington, D.C.: U.S. Government Printing Office, 1985.
47. Voytko ML, Olton DS, Richardson RT, Gorman LK, Tobin JR, Price DR. Basal forebrain lesions in monkeys disrupt attention but not learning and memory. J Neurosci 1994;14:167-86.
48. Whishaw IQ, Auer RN. Immediate and long-lasting effects of MK-801 on motor activity, spatial navigation in the swimming pool and EEG in the rat. Psychopharmacology 1989;98:500-7.
49. Wozniak DF, Olney JW, Kettinger III L, Price M, Miller JP. Behavioral effects of MK-801 in the rat. Psychopharmacology 1990;101:47-56.